Paysign Inc (PAYS)

[ebrie014]

This is just my own thoughts however If I were to guess, Q1 won't see a major turn in general plasma volumes - maybe a tad higher than Q4 (though it might show new organic growth in centers which would help shadow the potential drop in volume yoy) and we can hopefully bank on some of the new initiatives to diversify away from plasma (pharma, reloadable cards, etc..).

If we look at the trends I would say Q2 will be generally better for volumes given the vaccination rates and COVID cases in the US so maybe we are at a turning point as the market is typically forward-looking (hopefully mgmt can provide some insight on, for example, April volumes to guide us to that conclusion). Also, Q1 is seasonally the weakest Q for PAYS so I'm not too concerned that if it's slightly weaker, Q2-Q4 could rebound and end the year quite strong vs. 2020.

While I have divested some of my PAYS to build a house and other properties, I still have a bit because I enjoy following the story and trust management - it's been a long journey with them so I hope we turn this ship around and continue the long term trend higher. I am not following this as closely however based on the current price it looks like a reasonable buying opportunity given some of the forward prospects and new initiatives the Company is launching. I'm sure mgmt is kicking themselves for not raising money when it we hit near 18$ (would have been good war chess for acquisitions). Nevertheless, the forward-looking statement will be key (I don't expect any full year guidance until later on) but at least some update on the new programs, volume trends, and general marekt prospects would be nice. They should also provide some general comment to the executive departure in terms of being transparent that it's nothing to worry about and just general churn.

Best of luck.

E.